4142:TPE
Adimmune Corp
NT$16.15
arrow_downward
-0.62%(-0.10) 1D
ඉල් 18, 13.30.02 ග්රිමවේ+8 · TWD
search
සියලු සංකේත
| සංකේතය | මිල | වෙනස් කිරීම | % වෙනස |
|---|
insights_auto4142 සඳහා ඉහළම ඇතුළාන්තයන් උත්පාදනය කරමින්...
විවෘත කරන්න
NT$16.35
ඉහළ
NT$16.55
පහළ
NT$16.00
වෙ.පො ප්රාග්ධනය
බි6.94
දළ පරිමාව
මි1.09
හඬ පරිමාණය
ද534.85
සති-52 ඉහළ
NT$21.50
සති-52 පහළ
NT$15.65
EPS
-NT$0.34
ගෙවිය යුතු කොටස්
මි235.29
සේවකයින් ගණන
564
විවෘත කරන්න
NT$16.35
ඉහළ
NT$16.55
පහළ
NT$16.00
වෙ.පො ප්රාග්ධනය
බි6.94
දළ පරිමාව
මි1.09
හඬ පරිමාණය
ද534.85
සති-52 ඉහළ
NT$21.50
සති-52 පහළ
NT$15.65
EPS
-NT$0.34
ගෙවිය යුතු කොටස්
මි235.29
සේවකයින් ගණන
564
පුවත් සහ කථා
වෙබ් මූලාශ්ර සහ ප්රවෘත්ති හවුල්කරුවන්ගෙන්
ChartMill
·
මිනිත්තු 56කට පෙර
S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%
BigGo Finance
·
පැය 1කට පෙර
S&P 500's Shiller P/E Tops 40 Again, Echoing Dot-Com Era Valuations
ChartMill
·
පැය 1කට පෙර
S&P 500 Unusual Volume Movers: Nov. 18, 2026
Traders Union
·
මිනිත්තු 42කට පෙර
S&P 500 movement in 1992–2010 often tied to valuation multiples, Brett Caughran notes
පැතිකඩ
Adimmune Corporation is a Taiwanese pharmaceutical company engaged in the research, development, manufacturing, and sales of medicines and vaccines for both humans and animals. Its products are supplied to both local and international markets.
Founded in 1965 and headquartered in Tanzi District, Taichung, it has a market cap of US$230 million, 564 employees and annual sales of $106 million as of 2026.
Adimmune continues to seek expansion its role in the regional pharmaceutical and vaccine industry through international collaborations.
In January 2021, Adimmune Corporation announced a partnership with Sam Chun Dang Pharm to jointly develop an injectable medication used to treat macular disease.
In July 2021, the company announced that its first overseas manufacturing site will be situated in the Special Economic Zone in East Java, Indonesia, aiming to launch clinical trials for its COVID-19 vaccine in Indonesia early 2022.
In August 2021, Adimmune Corporation signed a memorandum of understanding with Becton, Dickinson and Company to strengthen its international pharmaceutical collaboration. Wikipedia
Adimmune Corp ගැන